Azzur Group and BioSPEQ Announce Merger
PTSM: Pharmaceutical Technology Sourcing and Management
The Azzur Group and BioSPEQ merger will increase consulting services and project resources within the life-sciences industry.
Azzur Group and BioSPEQ, a California-based consulting firm, have merged to create a union that will provide consulting services and project resources within the QA, laboratory, clinical, information technology, business processes, manufacturing, operations, and R&D settings.
The Azzur-BioSPEQ merger is the latest in a series of new developments for Azzur Group. Earlier this month, the company acquired Azot and formed Azzur Engineering.
Azzur Group’s main office is located in Willow Grove, PA, with additional offices in Frederick, MD, San Antonio, TX, Cambridge, MA, Cary, NC and Palo Alto, CA. BioSPEQ is headquartered in Irvine, CA with additional offices in Lexington, MA and San Diego, CA.
Source: Azzur Group
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
